Current location:home page > Food News

Curcumin Inhibits Prostate Cancer Metastases

admin2 days agoFood News5
Curcumin, an active component of turmeric that has been found to inhibit inflammation, may help slow…
Curcumin, an active component of turmeric that has been found to inhibit inflammation, may help slow down prostate cancer metastases, according to a new study published in the journal Carcinogenesis.

Researchers at Ludwig-Maximilians-University Munich have been studying curcumin’s role in inhibiting the formation of cancer metastases. In a previous study the researchers demonstrated that the substance reduces statistically significantly the formation of lung metastases in an animal model of advanced breast cancer.

The new study was designed to investigate the efficacy of curcumin in the prevention of prostate cancer metastases, and to determine the agent’s mechanism of action. The researchers first examined the molecular processes that are abnormally regulated in prostate carcinoma cells. Breast and prostate cancers are often associated with latent or chronic inflammatory reactions, and in both cases, the tumor cells were found to produce pro-inflammatory immunomodulators including the cytokines CXCL1 und CXCL2. The researchers found that curcumin specifically decreases the expression of these two proteins, and in a mouse model, this effect correlated with a decline in the incidence of metastases.

“Due to the action of curcumin, the tumor cells synthesize smaller amounts of cytokines that promote metastasis," they said. “As a consequence, the frequency of metastasis formation in the lungs is significantly reduced, in animals with breast cancer, as we showed previously, or carcinoma of the prostate, as demonstrated in our new study."

Early this year, researchers at Jefferson's Kimmel Cancer Center found curcumin helped slow down tumor growth in castration-resistant prostate cancer patients on androgen deprivation therapy (ADT). Curcumin was found to suppress p300 and CPB, two nuclear receptor activators that help tumor cells bypass ADT, thus squashing the success of the therapy.

Related articles

Yum's China rebound dimmed by India, Pizza Hut weakness

Yum Brands Inc on Wednesday said its KFC business bounced back in China, its No. 1 market, but its s…

McDonald's feels 'bit deceived' by audit results from China plant

McDonald's Corp Chief Executive Don Thompson said the company feels "a bit deceived" by the audit it…

Burger King in talks to buy Canada's Tim Hortons

Burger King is in talks to acquire Canadian coffee and doughnut chain Tim Hortons Inc in a deal that…

McDonald's shareholders approve chain's executive compensation

McDonald's shareholders approve chain's executive compensation

McDonald's Corp (MCD.N) shareholders on Thursday overwhelmingly approved an advisory measure on exec…

Fresh or chilled asparagus account for half of Peru's air shipments

According to the Peruvian Foreign Trade Society (Comex Peru), Peru exported 74,774 tons of agricultu…

McDonald's Thompson discusses slipping July results

Global comparable sales for McDonald's Corporation slipped 2.5 percent in July. Sales for the US wer…